How to Take Advantage of Chemours Stock's Dip

The security currently sports affordably priced premiums

May 19, 2021 at 11:19 AM
facebook twitter linkedin


Chemical concern Chemours Co (NYSE:CC) took a trip to the earnings confessional on May 3, reporting first-quarter earnings and revenue that were well above Wall Street's forecasts, leading the company to raise its full-year guidance. In response, the shares soared on the charts to their highest level in two years. The stock has since consolidated slightly, which makes now the ideal time to buy CC calls.
 
There's plenty of room for optimism to grow amongst analysts as well. Currently, just three of the eight in coverage carry a "buy" or better rating, while the rest all stand at a tepid "hold." In addition, short sellers are hitting the exits, but the 8.11 million shares sold short represent 5% of the stock's available float. At the stock's average daily pace of trading, it would take a little over a week to buy back these bearish bets.

A shift in sentiment in the options pits could provide additional tailwinds, too. This is per the security's 50-day put/call volume ratio of 1.25 at the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), which stands higher than 96% of readings from the past year.

Lastly, now seems to be an affordable time to weigh in on CC's next move with options, as the stock's Schaeffer's Volatility Index (SVI) of 50% sits lower than 80% of readings in its annual range, indicating options are particularly cheap right now -- a boon for premium buyers. Our recommended call has a leverage ratio of 5.9 and will double in value on a 16.3% rise in the underlying equity.

Subscribers to Schaeffer's Weekend Trader options recommendation service received this CC commentary on Sunday night, along with a detailed options trade recommendation -- including complete entry and exit parameters. Learn more about why Weekend Trader is one of our most popular options trading services.

Grab your FREE Eternal Contrarian report!


 




 
Special Offers from Schaeffer's Trading Partners